
With no product to sell, SuppCo is betting on clarity, scale, and community-driven science.
SuppCo is launching its own original research program—marking a meaningful shift in how supplement efficacy is studied, discussed, and understood.
Rather than funding studies to validate products or marketing claims, SuppCo’s research arm is designed to answer the questions users actually care about but the industry rarely studies. Not because those questions lack importance—but because they often lack a clean commercial incentive.
Questions like:
By sitting at the intersection of real-world supplement usage and large-scale data, SuppCo sees patterns most brands never do: long-term use, stacked protocols, and outcomes that don’t fit neatly into a label claim.
The defining principle of SuppCo’s research program is simple: no commercial bias.
This work isn’t designed to promote brands, formulations, or tidy conclusions. Instead, it focuses on nutrient-level efficacy and real-world combinations—even when results are mixed, nuanced, or inconvenient.
That means:
It’s harder to fund. Harder to run. And harder to market. But it’s also the kind of research that actually advances understanding.
SuppCo’s first original study focuses on one of the most researched—and still misunderstood—supplements in the world: creatine.
In partnership with Oklahoma State University, the study is being conducted under an Institutional Review Board (IRB), following formal academic and ethical standards.
Rather than testing a single outcome in a narrow population, this study takes a broader lens. Participants will be surveyed on:
The goal isn’t a headline—it’s perspective.
Once complete, SuppCo will publish a public-facing report and submit findings for peer-reviewed publication, contributing directly to the scientific literature.
SuppCo’s community has already shown it wants more than content—it wants participation.
As users began commenting, questioning, and sharing experiences across the platform, research became the natural next step. This program turns users from passive readers into active contributors—helping generate evidence, not just debate it.
This isn’t a product launch. It’s an infrastructure move.
By removing the need to sell an outcome, SuppCo is creating space for the kind of research the supplement industry has long avoided—but desperately needs. This model doesn’t just inform better decisions. It raises the standard for how evidence is generated across the entire category.